Disclosures for "Serum And Cerebrospinal Fluid Antibody Signatures Track With Outcome Of Neurologic Post-Acute Sequelae Of SARS-Cov-2 Infection (NeuroPASC)")
-
The institution of Dr. Spatola has received research support from American Academy of Neurology. Dr. Spatola has received research support from Swiss National Funding. The institution of Dr. Spatola has received research support from La Caixa Foundation.
-
Dr. Dinoto has nothing to disclose.
-
Silvia Bozzetti has nothing to disclose.
-
Ms. Chiodega has nothing to disclose.
-
Sergio Ferrari has nothing to disclose.
-
Dr. Mariotto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
-
Galit Alter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Galit Alter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Galit Alter has received stock or an ownership interest from SeromYx Systems. Galit Alter has received stock or an ownership interest from Leyden Labs. An immediate family member of Galit Alter has received stock or an ownership interest from Leyden Labs. The institution of Galit Alter has received research support from BioNetch. The institution of Galit Alter has received research support from Sanofi. The institution of Galit Alter has received research support from Medicago. Galit Alter has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Galit Alter has received publishing royalties from a publication relating to health care. Galit Alter has received personal compensation in the range of $10,000-$49,999 for serving as a Senior Director Technology with Leyden Labs.